NCT00159445View on ClinicalTrials.gov

Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2007

Study Completion Date

November 30, 2007

Conditions
Colorectal CancerColon Cancer
Interventions
DRUG

gemcitabine, capecitabine

Trial Locations (1)

90033

U.S.C./Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

lead

University of Southern California

OTHER

NCT00159445 - Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter